Phathom Pharmaceuticals PHAT Stock
Phathom Pharmaceuticals Price Chart
Phathom Pharmaceuticals PHAT Financial and Trading Overview
| Phathom Pharmaceuticals stock price | 10.14 USD |
| Previous Close | 12.77 USD |
| Open | 12.71 USD |
| Bid | 0 USD x 1200 |
| Ask | 0 USD x 3200 |
| Day's Range | 12.34 - 12.81 USD |
| 52 Week Range | 5.84 - 14.45 USD |
| Volume | 166.19K USD |
| Avg. Volume | 396.91K USD |
| Market Cap | 711.87M USD |
| Beta (5Y Monthly) | 0.36034 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.93 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 18.5 USD |
PHAT Valuation Measures
| Enterprise Value | 639.95M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.381132 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.903 |
Trading Information
Phathom Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.36034 |
| 52-Week Change | 101.27% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 14.45 USD |
| 52 Week Low | 5.84 USD |
| 50-Day Moving Average | 11.4 USD |
| 200-Day Moving Average | 10 USD |
PHAT Share Statistics
| Avg. Volume (3 month) | 396.91K USD |
| Avg. Daily Volume (10-Days) | 257.55K USD |
| Shares Outstanding | 56.41M |
| Float | 28.3M |
| Short Ratio | 8.92 |
| % Held by Insiders | 21.51% |
| % Held by Institutions | 70.56% |
| Shares Short | 4.16M |
| Short % of Float | 11.22% |
| Short % of Shares Outstanding | 7.58% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -70.21% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -163972992 USD |
| Net Income Avi to Common (ttm) | -194872000 USD |
| Diluted EPS (ttm) | -4.73 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 129.57M USD |
| Total Cash Per Share (mrq) | 2.97 USD |
| Total Debt (mrq) | 212.97M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 9.682 |
| Book Value Per Share (mrq) | -2.07 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -141442000 USD |
| Levered Free Cash Flow (ttm) | -96830752 USD |
Profile of Phathom Pharmaceuticals
| Country | United States |
| State | NJ |
| City | Florham Park |
| Address | 100 Campus Drive |
| ZIP | 07932 |
| Phone | 877 742 8466 |
| Website | https://www.phathompharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 112 |
Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
Q&A For Phathom Pharmaceuticals Stock
What is a current PHAT stock price?
Phathom Pharmaceuticals PHAT stock price today per share is 10.14 USD.
How to purchase Phathom Pharmaceuticals stock?
You can buy PHAT shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Phathom Pharmaceuticals?
The stock symbol or ticker of Phathom Pharmaceuticals is PHAT.
Which industry does the Phathom Pharmaceuticals company belong to?
The Phathom Pharmaceuticals industry is Biotechnology.
How many shares does Phathom Pharmaceuticals have in circulation?
The max supply of Phathom Pharmaceuticals shares is 58.48M.
What is Phathom Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Phathom Pharmaceuticals PE Ratio is now.
What was Phathom Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Phathom Pharmaceuticals EPS is -3.93 USD over the trailing 12 months.
Which sector does the Phathom Pharmaceuticals company belong to?
The Phathom Pharmaceuticals sector is Healthcare.
Phathom Pharmaceuticals PHAT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}